







To find out why GuruFocus thinks data on insider trade are interesting, read
| Symbol | Company | Insider | Position | Date | Buy/Sell | Shares | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Yield (%) | P/E | Market Cap ($M) | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | SGEN | Seattle Genetic... | HIMES VAUGHN B | EVP, Tech. Ops. & Proc. Sci. | 2013-06-13 | Sell | 10,000 | $32.11 | 321.1 | 0.28 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | AKKARAJU SRINIVAS | Director | 2013-06-14 | Sell | 5,000 | $32.75 | 163.8 | -1.68 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | SIEGALL CLAY B | President and CEO (Click for the stocks that their CEOs have bought) | 2013-06-03 | Sell | 2,000 | $33.88 | 67.8 | -4.96 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | AKKARAJU SRINIVAS | Director | 2013-05-10 | Sell | 17,500 | $37.17 | 650.5 | -13.37 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | SIEGALL CLAY B | President and CEO | 2013-05-01 | Sell | 2,000 | $36.58 | 73.2 | -11.97 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | SIEGALL CLAY B | President and CEO | 2013-04-01 | Sell | 2,000 | $35.53 | 71.1 | -9.37 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | BOERNER CHRISTOPHER S. | SVP, Commercial | 2013-03-15 | Sell | 8,500 | $33.61 | 285.7 | -4.2 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | DOBMEIER ERIC | COO | 2013-03-11 | Sell | 60,000 | $31.16 | 1869.6 | 3.34 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | SIMPSON TODD E | CFO | 2013-03-07 | Sell | 49,718 | $30.75 | 1528.8 | 4.72 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | DOBMEIER ERIC | COO | 2013-03-06 | Sell | 100,000 | $29.68 | 2968 | 8.49 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | SIEGALL CLAY B | President and CEO | 2013-03-05 | Sell | 95,750 | $28.71 | 2749 | 12.16 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | GRYSKA DAVID W | Director | 2013-02-25 | Sell | 10,000 | $27.17 | 271.7 | 18.51 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | SIEGALL CLAY B | President and CEO | 2013-02-01 | Sell | 2,000 | $29.61 | 59.2 | 8.75 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | Reynolds Thomas C | Chief Medical Officer | 2013-01-28 | Sell | 7,290 | $30.09 | 219.4 | 7.01 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | Reynolds Thomas C | Chief Medical Officer | 2013-01-15 | Sell | 125,079 | $28 | 3502.2 | 15 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | SIEGALL CLAY B | President and CEO | 2013-01-04 | Sell | 8,249 | $24.13 | 199 | 33.44 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | DOBMEIER ERIC | COO | 2013-01-04 | Sell | 50,983 | $24.95 | 1272 | 29.06 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | DOBMEIER ERIC | COO | 2012-12-17 | Sell | 50,000 | $23.7 | 1185 | 35.86 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | Reynolds Thomas C | Chief Medical Officer | 2012-12-10 | Sell | 66,588 | $25.77 | 1716 | 24.95 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | Reynolds Thomas C | Chief Medical Officer | 2012-12-05 | Sell | 40,000 | $25.59 | 1023.6 | 25.83 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | SIEGALL CLAY B | President and CEO | 2012-12-03 | Sell | 8,250 | $25.19 | 207.8 | 27.83 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | Reynolds Thomas C | Chief Medical Officer | 2012-12-03 | Sell | 40,000 | $25.41 | 1016.4 | 26.72 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | Reynolds Thomas C | Chief Medical Officer | 2012-11-26 | Sell | 30,000 | $25.34 | 760.2 | 27.07 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | Reynolds Thomas C | Chief Medical Officer | 2012-11-20 | Sell | 20,000 | $24.95 | 499 | 29.06 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | DOBMEIER ERIC | COO | 2012-11-13 | Sell | 27,327 | $23.59 | 644.6 | 36.5 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | SIEGALL CLAY B | President and CEO | 2012-11-01 | Sell | 8,250 | $25.51 | 210.5 | 26.23 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | DOBMEIER ERIC | COO | 2012-10-15 | Sell | 25,000 | $25.01 | 625.3 | 28.75 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | SIEGALL CLAY B | President and CEO | 2012-10-01 | Sell | 8,250 | $26.59 | 219.4 | 21.1 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | HIMES VAUGHN B | EVP, Tech. Ops. & Proc. Sci. | 2012-09-10 | Sell | 10,000 | $28.79 | 287.9 | 11.84 | 0.00 | 0.00 | 3878.07 | |
![]() | SGEN | Seattle Genetic... | Reynolds Thomas C | Chief Medical Officer | 2012-09-06 | Sell | 48,540 | $29.75 | 1444.1 | 8.24 | 0.00 | 0.00 | 3878.07 |
| Guru Name | Portfolio Date* | Current Shares (?) | % of Total Assets (?) | Change from Last Holdings (?) | |
|---|---|---|---|---|---|
| Columbia Wanger | 2013-03-31 | 8,625,000 | 1.3% | -3.8% | |
| PRIMECAP Management | 2013-03-31 | 10,429,099 | 0.55% | -0.89% | |
| RS Investment Management | 2013-03-31 | 398,920 | 0.1% | +1.52% | |
| Manning & Napier Advisors, Inc | 2013-03-31 | 492,200 | 0.09% | +46.89% | |
| Jim Simons | 2013-03-31 | 219,613 | 0.02% | -47.07% | |
| Steven Cohen | 2013-03-31 | 0 | 0% | Sold Out | |
Most recent portfolio changes are included for Premium Members only!
| |||||
Add Notes, Comments or Ask Questions
Comments